| [1] Bergelson J M, Cunningham J A, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, 1997,275:1320-1323.
[2] Tomko R, Xu R, Philipson L. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA, 1997,94:3352-3356.
[3] Henry L J, Xia D, Wilke M E, et al. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol, 1994,68:5239-5246.
[4] Nemerow G. Cell receptors involved in adenovirus entry. Virology,2000,274:1-4.
[5] Bai M, Harfe B, Freimuth P. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells. J Virol, 1993,67:5198-5205.
[6] Wickham T, Mathias P, Cheresh D, et al. Integrins alpha V Beta3 and alpha V Beta5 promote adenovirus internalization but not virus attachment. Cell, 1993,73:309-319.
[7] Li Y, Pong R, Bergelson J, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res, 1999,59:325-330.
[8] Cripe T, Dunphy E, Holub A, et al. Fiber knob modifications overcome low, heterogeneous expression of the Coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. Cancer Res, 2001,61:2953-2960.
[9] Asaoka K, Tada M, Sawamura Y, et al. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. J Neurosurg, 2000,92:1002-1008.
[10] Naoki Okada,Yasushige Masunaga,Yuka Okada, et al. Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors. Cancer Gene Therapy, 2003,10:421-431.
[11] Dmitriev I, Krasnykh V, Miller C R, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a Coxsackievirus. J Virol, 1998,72:9706-9713.
[12] Krasnykh V, Dmitriev I, Mikheeva G, et al. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol, 1998,72:1844-1852.
[13] Bouri K, Feero W G, Myerburg M M, et al. Poly-lysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum Gene Ther, 1999, 10:1633-1640.
[14] Gonzalez R, Vereecque R, Wickham T J, et al. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Therapy, 1999,6:314-320.
[15] Ng P, Graham F L. Methods in Molecular Medicine. Gene Therapy Protocols. 2nd ed. Totowa: Human Press Inc, 2002, 69: 409.
[16] Ternette N, Tippler B, Uberla K, et al. Immunogenicity and efficacy of codon-optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. Vaccine, 2007,25:7271-7279.
[17] Mizuguchi H, Koizumi N, Hosono T, et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Therapy, 2001,8:730-735.
[18] Stefan Worgall, Annette Busch, Michael Rivara, et al. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. J Virol, 2004,5: 2572-2580. |
